Patent ID: 7402704
Filing Date: 2008-07-22
Classification: A61P,C07C,C07D

Abstract:
1. A compound having the formula: or pharmaceutically acceptable salts, solvates, stereoisomers, or prodrugs thereof, wherein: R R R any fused ring portion, cycloalkyl portion, or aryl is optionally substituted with from one to four members selected from the group consisting of H, halogen, —CN, —NO wherein X is a branched or straight chain (C each occurrence of R′ is independently H or an unsubstituted member selected from the group consisting of (C each occurrence of R″ is independently an unsubstituted member selected from the group consisting of (C R with the proviso that the compound is other than 2-{4-[4-(1-Hydroxy-1-methyl-ethyl)-benzenesulfonyl]-phenyl}-propan-2-ol or 1-(1-chloro-1-methylethyl)-4-(phenylsulfonyl)benzene.